Strong Relative Performance Against Benchmarks
Venus Remedies has demonstrated exceptional returns compared to the broader market, as represented by the Sensex. Over the past week, the stock gained 3.66%, markedly higher than the Sensex's modest 0.42% rise. This outperformance extends over longer periods, with the stock delivering a remarkable 15.37% return in the last month against the Sensex's 0.39%. Most notably, the year-to-date (YTD) return for Venus Remedies stands at an extraordinary 157.21%, dwarfing the Sensex's 9.51% gain. Over one year, the stock's appreciation reaches 160.02%, while the Sensex managed just 9.64%. Even over three and five years, Venus Remedies has outpaced the benchmark by a wide margin, with gains of 347.97% and 523.54% respectively, compared to the Sensex's 40.68% and 85.99%.
Nearing 52-Week High and Daily Trading Dynamics
On 22-Dec, Venus Remedies traded close to its 52-week high of ₹839.95, finishing just 3.62% below this peak. The stock touched an intraday high of ₹810.75, representing a 5% increase from the previous close, while the intraday low was ₹755, down 2.22%. This volatility within the session indicates active trading interest, although the weighted average price suggests that a larger volume of shares exchanged hands nearer to the day's lower price levels. Despite this, the stock's ability to close near its high points to underlying buying strength.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Technical Indicators and Moving Averages Support Uptrend
Venus Remedies is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning is a strong indicator of sustained bullish momentum, often interpreted by market participants as a signal of continued upward potential. The stock's consecutive gains over the last two days, amounting to a 6.81% return, further reinforce this positive trend.
Investor Participation and Liquidity Considerations
While the stock has shown impressive price appreciation, there has been a decline in investor participation as measured by delivery volume. On 19 Dec, the delivery volume stood at 2.19 thousand shares, representing a 14.6% decrease compared to the five-day average delivery volume. This reduction in investor involvement could suggest some caution among shareholders or a temporary pause in fresh buying interest. Nevertheless, liquidity remains adequate, with the stock's traded value supporting transactions of approximately ₹0.06 crore based on 2% of the five-day average traded value, ensuring that investors can enter or exit positions without significant price impact.
Thinking about Venus Remedies? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this Microcap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Conclusion: Why Venus Remedies Is Rising
The rise in Venus Remedies' share price on 22-Dec is underpinned by its exceptional performance relative to the Sensex and sector peers, strong technical indicators, and proximity to its 52-week high. The stock’s sustained gains over multiple time horizons highlight robust investor confidence and favourable market sentiment. Although there is a slight dip in delivery volumes, the overall liquidity and trading activity remain sufficient to support continued interest. Investors appear to be rewarding the company’s consistent upward trajectory, making Venus Remedies a standout performer in the pharmaceutical and healthcare segment.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
